Skip to main content
Top
Published in: Journal of General Internal Medicine 12/2018

01-12-2018 | Concise Research Reports

Access to Treatment for Alcohol Use Disorder at US Health Centers: a National Study

Authors: Benjamin Bearnot, MD, Nancy A. Rigotti, MD, Travis P. Baggett, MD, MPH

Published in: Journal of General Internal Medicine | Issue 12/2018

Login to get access

Excerpt

Alcohol use disorder (AUD) is a substantial and growing public health problem in the USA,1 particularly among medically underserved and low-income populations.2 Treatment rates for AUD remain low despite the existence of evidence-based behavioral and pharmacologic treatment approaches.3 Little is known about the barriers to accessing AUD treatment at federally funded US health centers, which provide care to 26 million vulnerable individuals annually. The aim of this study was to examine the continuum of alcohol use disorder care, location of treatment delivery, and barriers to receiving AUD treatment among adult patients with symptoms of AUD attending HRSA-funded health centers. …
Literature
1.
go back to reference Grant BF, Chou SP, Saha TD, Pickering RP, Kerridge BT, Ruan WJ, et al. Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001-2002 to 2012-2013: results from the National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry. 2017; 74(9): 911–923.CrossRef Grant BF, Chou SP, Saha TD, Pickering RP, Kerridge BT, Ruan WJ, et al. Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001-2002 to 2012-2013: results from the National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry. 2017; 74(9): 911–923.CrossRef
2.
go back to reference Storholm ED, Ober AJ, Hunter SB, Becker KM, Iyiewuare PO, Pham C, Watkins KE. Barriers to integrating the continuum of care for opioid and alcohol use disorders in primary care: A qualitative longitudinal study. J Subst Abuse Treat. 2017; 83: 45–54.CrossRef Storholm ED, Ober AJ, Hunter SB, Becker KM, Iyiewuare PO, Pham C, Watkins KE. Barriers to integrating the continuum of care for opioid and alcohol use disorders in primary care: A qualitative longitudinal study. J Subst Abuse Treat. 2017; 83: 45–54.CrossRef
3.
go back to reference Cohen E, Feinn R, Arias A, Kranzler HR. Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug & Alcohol Depend. 2007; 86(2): 214–21.CrossRef Cohen E, Feinn R, Arias A, Kranzler HR. Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug & Alcohol Depend. 2007; 86(2): 214–21.CrossRef
6.
go back to reference American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edition. Arlington, VA: APA; 2013.CrossRef American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edition. Arlington, VA: APA; 2013.CrossRef
Metadata
Title
Access to Treatment for Alcohol Use Disorder at US Health Centers: a National Study
Authors
Benjamin Bearnot, MD
Nancy A. Rigotti, MD
Travis P. Baggett, MD, MPH
Publication date
01-12-2018
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 12/2018
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4631-3

Other articles of this Issue 12/2018

Journal of General Internal Medicine 12/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.